Want to keep track of the conversation around the FDA special hearings on internet and social media?

This #FDASM aggregator site from Ignite Health should do the trick.

The site was created to capture conversations and resources related to the Nov. 12-13 FDA public hearing on how FDA-regulated product manufacturers use the Internet and social media.

A mobile version of the site is also available.

Check out some of the most recent tweets on the site:

• From @rohal: Dermatologists, Med Oncologists are the Top Phys Spec Groups Communicating with Patients Online http://bit.ly/bHvqoL #hcsmeu #pharma #hcsm

These days, it’s common for consumers to discuss drugs and treatments on health care social networks like WebMD, as well as on general social networks like Twitter.

Yet the pharmaceutical industry has thus far been unable to participate in social media — not because they are prohibited by law, but because there is a lack of clear regulatory guidelines for marketing on social networks and other web sites.

Still, in April, the FDA sent warning letters to 14 companies, claiming they violated regulations regarding presentation of fair balance in search engine ads, according to AdvertisingAge.